Fresh fund, same plan

Advent Venture Partners plans to stick with its long-standing investment strategy for its second dedicated life sciences fund, Advent Life Sciences Fund II, which the firm closed last week with £145.5 million ($234.3 million).

"The investment strategy we put in place with the 2006 fund is the same one we applied in ALSF I and will apply in ALSF II," said the firm's Raj Parekh...